This trial is active, not recruiting.

Condition schizophrenia
Treatments magnetic resonance imaging, evaluation neuropsychological
Sponsor Assistance Publique Hopitaux De Marseille
Start date January 2011
End date January 2015
Trial size 100 participants
Trial identifier NCT01295411, 2010-29, 2010-A01421-38


The aim of the investigators analysis is to identify the neural correlates of quality of life scores in schizophrenia. For this, the investigators will constitute group of patients according to their quality of life scores and the investigators will analyze their differences in patterns of brain structures and activations.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Intervention model single group assignment
Masking open label
magnetic resonance imaging
evaluation neuropsychological

Primary Outcomes

to study the relationships between quality of life and the morphologic, structural and functional substrates in schizophrenia
time frame: 36 months

Secondary Outcomes

to determine whether quality of life is correlated with brain modifications using functional Magnetic Resonance Imaging
time frame: 36 months

Eligibility Criteria

Male or female participants from 18 years up to 40 years old.

Inclusion Criteria: - diagnosis of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria (American Psychiatric Association(APA), 1994), - age over 18 years, - informed consent to participate in the studies - French as native language Exclusion Criteria: - diagnosis other than schizophrenia on Axis I of DSM-IV, - decompensated organic disease and mental retardation

Additional Information

Official title Morphological, Structural and Functional Neural Substrates of Quality of Life in Schizophrenia
Trial information was received from ClinicalTrials.gov and was last updated in April 2015.
Information provided to ClinicalTrials.gov by Assistance Publique Hopitaux De Marseille.